Home > Insider Trading > Filing (0001209191-15-026153)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
944809	Opko Health Inc.	OPK	Pharmaceutical Preparations (2834)	752402409

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1356197	Adam Logal	4400 Biscayne Blvd. Miami FL 33137	Sr. Vice President, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-03-12	60,000	$1.16	60,000	No	4	M	Direct
Common Stock	Disposition	2015-03-12	4,767	$14.60	55,233	No	4	F	Direct
Common Stock	Acquisiton	2015-03-12	35,000	$1.65	90,233	No	4	M	Direct
Common Stock	Disposition	2015-03-12	3,956	$14.60	86,277	No	4	F	Direct
Common Stock	Disposition	2015-03-13	24	$14.56	86,253	No	4	S	Direct
Common Stock	Disposition	2015-03-13	576	$14.61	85,677	No	4	S	Direct
Common Stock	Disposition	2015-03-13	500	$14.62	85,177	No	4	S	Direct
Common Stock	Disposition	2015-03-13	38,888	$14.64	46,289	No	4	S	Direct
Common Stock	Disposition	2015-03-13	1,500	$14.65	44,789	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-12	60,000	$0.00	60,000	$1.16
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-12	35,000	$0.00	35,000	$1.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-05-05	2016-05-04	No	4	M	Direct
0	2012-04-28	2015-04-27	No	4	M	Direct

Footnotes

Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. The reporting person has retained the net number of shares issued upon the exercise of the option (55,233 shares).
Closing market price of the Company's common stock on the transaction date.
Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. The reporting person has retained the net number of shares issued upon the exercise of the option (31,044 shares).
The reporting person sold the Common Stock to satisfy federal and/or state income tax obligations in connection with his acquisition of shares of OPKO Common Stock through net exercise on March 12, 2015.